MX9300100A - Peptidos hemorreguladores. - Google Patents

Peptidos hemorreguladores.

Info

Publication number
MX9300100A
MX9300100A MX9300100A MX9300100A MX9300100A MX 9300100 A MX9300100 A MX 9300100A MX 9300100 A MX9300100 A MX 9300100A MX 9300100 A MX9300100 A MX 9300100A MX 9300100 A MX9300100 A MX 9300100A
Authority
MX
Mexico
Prior art keywords
hemoregulatory
peptides
hemoregulatory peptides
compounds
fungal
Prior art date
Application number
MX9300100A
Other languages
English (en)
Inventor
Pradip Kumar Bhatnagar
William Francis Huffman
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9300100A publication Critical patent/MX9300100A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención proporciona compuestos de la fórmula, general (A) en donde los compuestos tienen actividad hemorreguladora y pueden utilizarse para estimular la hematopoyesis y para la prevención y tratamiento de enfermedades infecciosas virales, micóticas y bacterianas.
MX9300100A 1992-01-10 1993-01-08 Peptidos hemorreguladores. MX9300100A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81902492A 1992-01-10 1992-01-10

Publications (1)

Publication Number Publication Date
MX9300100A true MX9300100A (es) 1994-04-29

Family

ID=25227024

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300100A MX9300100A (es) 1992-01-10 1993-01-08 Peptidos hemorreguladores.

Country Status (14)

Country Link
EP (1) EP0621788B1 (es)
JP (1) JPH07505864A (es)
CN (1) CN1077960A (es)
AT (1) ATE201693T1 (es)
AU (1) AU666516B2 (es)
CA (1) CA2127688A1 (es)
DE (1) DE69330268T2 (es)
ES (1) ES2159287T3 (es)
IL (1) IL104323A0 (es)
MX (1) MX9300100A (es)
NZ (1) NZ246805A (es)
SI (1) SI9300011A (es)
WO (1) WO1993013789A1 (es)
ZA (1) ZA93129B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011693A1 (en) * 1993-10-29 1995-05-04 Smithkline Beecham Corporation Hemoregulatory peptides
GB9425730D0 (en) * 1994-12-20 1995-02-22 Nycomed Pharma As Compounds
EP0874638A4 (en) * 1995-11-13 1999-07-21 Smithkline Beecham Corp HEMATOREGULATORS
US6407125B1 (en) 1995-12-29 2002-06-18 Novactyl, Inc. Pharmacological agent and method of treatment
US6743771B2 (en) 1995-12-29 2004-06-01 Novactyl, Inc. Methods and compositions for controlling protein assembly or aggregation
US6127393A (en) * 1995-12-29 2000-10-03 Novactyl, Inc. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method
US5767135A (en) * 1995-12-29 1998-06-16 Fernandez-Pol; Jose Alberto Antiviral agent
US6579891B1 (en) 1995-12-29 2003-06-17 Novactyl, Inc. Agent and method for prevention and treatment of cancer in animals
US6441009B1 (en) 1998-08-01 2002-08-27 Novactyl, Inc. Agent and method of preventing and treating heavy metal exposure and toxicity
US6403618B1 (en) 2000-02-15 2002-06-11 Novactyl, Inc. Agent and method for controlling angiogenesis
FR2966827B1 (fr) * 2010-10-27 2014-08-22 Kimonella Ventures Ltd Compose peptidique utile pour l'inhibition de la formation de plaques amyloides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77875C (fi) * 1982-11-26 1989-05-10 Nyegaard & Co As Foerfarande foer framstaellning av nya terapeutiskt anvaendbara peptider.
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds
NO884054D0 (no) * 1988-09-13 1988-09-13 Bio Tech As Nytt pentapeptid og fremgangsmaate for fremstilling derav.
GB8821785D0 (en) * 1988-09-16 1988-10-19 Nycomed As Peptide compounds
ZW11290A1 (en) * 1989-07-14 1990-10-31 Smithkline Beecham Corp Hemoregulatory peptides
GB9211677D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
LV10288B (en) * 1992-06-02 1995-04-20 Hafslund Nycomed As Peptide compounds

Also Published As

Publication number Publication date
AU3440293A (en) 1993-08-03
CN1077960A (zh) 1993-11-03
ATE201693T1 (de) 2001-06-15
ES2159287T3 (es) 2001-10-01
WO1993013789A1 (en) 1993-07-22
CA2127688A1 (en) 1993-07-22
DE69330268D1 (de) 2001-07-05
EP0621788A4 (en) 1997-03-05
AU666516B2 (en) 1996-02-15
SI9300011A (en) 1993-09-30
EP0621788A1 (en) 1994-11-02
ZA93129B (en) 1994-01-18
IL104323A0 (en) 1993-05-13
JPH07505864A (ja) 1995-06-29
NZ246805A (en) 1995-12-21
EP0621788B1 (en) 2001-05-30
DE69330268T2 (de) 2001-11-22

Similar Documents

Publication Publication Date Title
DE69831506D1 (en) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
DK0973735T3 (da) Polyaromatiske antivirale præparater
ATE245977T1 (de) Therapeutische substituierte guanidine
ATE157877T1 (de) Verbindung von nucleocidanaloga zur behandlung viraler infektionen
ES2159287T3 (es) Peptidos hemorreguladores.
ATE112289T1 (de) Hämoregulierende peptide.
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
DE69514928T2 (de) Gegen protozoen wirksamezyklische tetrapeptide
BR9611520A (pt) Composto hemo-reguladores.
RU93045696A (ru) Ингибиторы протеазы вируса иммунодефицита человека, полезные для лечения спида